impact of genetic mutations in gilteritinib treated patients with flt-3 mutated r/r aml
Published 5 years ago • 124 plays • Length 3:00Download video MP4
Download video MP3
Similar videos
-
1:28
patient-reported outcomes in flt3-mutated aml patients treated with gilteritinib plus azacitidine
-
1:37
emerging mutations at relapse in flt3-mutated r/r aml on gilteritinib
-
2:15
real-world analysis of gilteritinib for r/r flt3-mutated aml
-
1:12
gilteritinib relapse leads to loss of flt3-tkd mutation in patient with aml
-
0:49
treatment avenues for patients with r/r flt3-mutated aml: optimizing flt3 inhibitors
-
10:54
gilteritinib for flt3-mutant aml
-
1:06
investigating the molecular and clinical features of flt3-jmd mutations in aml
-
0:49
admiral update: co-occurrence of dnmt3a, npm1 & flt3 mutations in patients treated with gilteritinib
-
1:50
mechanisms of gilteritinib resistance in flt3-mutated aml
-
6:43
flt3 mutations’ impact on prognosis and treatment in aml
-
4:47
commodore: gilteritinib for the treatment of r/r flt3-mutated aml
-
8:31
gilteritinib in the treatment of flt3-mutated aml
-
3:21
admiral analysis: survival by mutation status in gilteritinib-treated flt3 r/r aml
-
1:23
the promise of combining venetoclax with gilteritinib for the treatment of flt3-mutated aml
-
3:03
prognostic impact of flt3-itd in older patients with aml
-
1:32
novel treatment combinations for flt3-mutated aml
-
1:44
new targets to treat acute myeloid leukemia (aml) with flt3 mutations
-
2:28
dr. levis on gilteritinib in relapsed/refractory flt3-mutated aml
-
2:27
gilteritinib maintenance after allogeneic transplantation in flt3-mutated aml